Prostate-specific Antigen Bounce After Prostate Brachytherapy: Review of a Confusing Phenomenon

Urology

Volumn 74, Issue 6, 2009, Pages 1183-1190

  Caloglu, Murat ^a,b   Ciezki, Jay ^b  

^a TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; PALLADIUM 103; PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; ANXIETY; BRACHYTHERAPY; CANCER STAGING; EXTERNAL BEAM RADIOTHERAPY; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; REVIEW;

BRACHYTHERAPY; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 70849085514     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.01.043     Document Type: Review

References (37)

1. Vicini F.A., Martinez A., Hanks G., et al. An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up. Cancer 95 (2002) 2126-2135
2. Ciezki J.P., Klein E.A., Angermeier K., et al. A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy. Int J Radiat Oncol Biol Phys. 60 (2004) 1347-1350
3. Saito S., Nagata H., Kosugi M., et al. Brachytherapy with permanent seed implantation. Int J Clin Oncol. 12 (2007) 395-407
4. Cooperberg M.R., Lubeck D.P., Meng M.V., et al. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol. 22 (2004) 2141-2149
5. Crook J., Gillan C., Yeung I., et al. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy. Int J Radiat Oncol Biol Phys. 69 (2007) 426-433
6. Critz F.A., Williams W.H., Benton J.B., et al. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer. J Urol. 163 (2000) 1085-1089
7. Wallner K.E., Blasko J., and Dattoli M.J. Evaluating cancer status. In: Wallner K.E., Blasko J., and Dattoli M.J. (Eds). Prostate Brachytherapy Made Complicated (1997), SmartMedicine Publishing, Seattle 14.11-14.15
8. Horwitz E.M., Levy L.B., Thames H.D., et al. Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis. Cancer 107 (2006) 1496-1502
9. Akyol F., Ozyigit G., Selek U., et al. PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone. Eur Urol. 48 (2005) 40-45
10. Mitchell D.M., Swindell R., Elliott T., et al. Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer. Radiother Oncol. 88 (2008) 102-107
11. Cavanagh W., Blasko J.C., Grimm P.D., et al. Transient elevation of serum prostate-specific antigen following (125)I/(103)Pd brachytherapy for localized prostate cancer. Semin Urol Oncol. 18 (2000) 160-165
12. Ciezki J.P., Reddy C.A., Garcia J., et al. PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time. Int J Radiat Oncol Biol Phys. 64 (2006) 512-517
13. Stock R.G., Stone N.N., and Cesaretti J.A. Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications. Int J Radiat Oncol Biol Phys. 56 (2003) 448-453
14. Toledano A., Chauveinc L., Flam T., et al. PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year follow up. Brachytherapy 5 (2006) 122-126
15. Reed D., Wallner K., Merrick G., et al. Clinical correlates to PSA spikes and positive repeat biopsies after prostate brachytherapy. Urology 62 (2003) 683-688
16. Das P., Chen M.H., Valentine K., et al. Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce. Int J Radiat Oncol Biol Phys. 54 (2002) 698-702
17. Singh A.K., Guion P., Susil R.C., et al. Early observed transient prostate-specific antigen elevations on a pilot study of external beam radiation therapy and fractionated MRI guided high dose rate brachytherapy boost. Radiol Oncol. 1 (2006) 28
18. Pruthi R.S. Re: prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer. J Urol. 164 (2000) 2031
19. Prestigiacomo A.F., and Stamey T.A. Physiological variation of serum prostate specific antigen in the 4.0-10.0 ng/ml: range in male volunteers. J Urol. 155 (1996) 1977-1980
20. Mitchell D.M., Swindell R., Elliott T., et al. Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer. Radiother Oncol. 88 (2008) 102-107
21. Crook J.M., Perry G.A., Robertson S., et al. Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients. Urology 45 (1995) 624-631 622
22. Smathers S., Wallner K., Sprouse J., et al. Temporary PSA rises and repeat prostate biopsies after brachytherapy. Int J Radiat Oncol Biol Phys. 50 (2001) 1207-1211
23. Tchetgen M.B., Song J.T., Strawderman M., et al. Ejaculation increases the serum prostate-specific antigen concentration. Urology 47 (1996) 511-516
24. Dew T., Coker C., Saadeh F., et al. Influence of investigative and operative procedures on serum prostate-specific antigen concentration. Ann Clin Biochem. 36 (1999) 340-346
25. Crawford III E.D., Mackenzie S.H., Safford H.R., et al. The effect of bicycle riding on serum prostate specific antigen levels. J Urol. 156 (1996) 103-105
26. Makarewicz R., Roszkowski K., Lebioda A., et al. PSA bounces after brachytherapy HDR and external beam radiation therapy for prostate cancer. Rep Pract Oncol Radiother. 11 (2006) 217-222
27. Rosser C.J., Kamat A.M., Wang X., et al. Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?. Urology 66 (2005) 327-331
28. Pickles T. Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls?. An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy. Int J Radiat Oncol Biol Phys. 64 (2006) 1355-1359
29. Merrick G.S., Butler W.M., Wallner K.E., et al. Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy. Brachytherapy 2 (2003) 181-188
30. Abel L., Zeroski D., Brammer S., et al. PSA spike after brachytherapy for localized prostate cancer. Urol Nurs. 27 (2007) 507-510 518; quiz 511
31. Critz F.A., Williams W.H., Levinson A.K., et al. Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: The relationship to patient age. J Urol. 170 (2003) 1864-1867
32. Patel C., Elshaikh M.A., Angermeier K., et al. PSA bounce predicts early success in patients with permanent iodine-125 prostate implant. Urology 63 (2004) 110-113
33. Merrick G.S., Butler W.M., Wallner K.E., et al. Prostate-specific antigen spikes after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 54 (2002) 450-456
34. Bostancic C., Merrick G.S., Butler W.M., et al. Isotope and patient age predict for PSA spikes after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys. 68 (2007) 1431-1437
35. Hanlon A.L., Pinover W.H., Horwitz E.M., et al. Patterns and fate of PSA bouncing following 3D-CRT. Int J Radiat Oncol Biol Phys. 50 (2001) 845-849
36. Critz F.A. Time to achieve a prostate specific antigen nadir of 0.2 ng/mL after simultaneous irradiation for prostate cancer. J Urol. 168 (2002) 2434-2438
37. Cesaretti J.A., Stone N.N., and Stock R.G. Urinary symptom flare following 1-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 56 (2003) 1085-1092